• EdU Imaging Kits (Cy3): S-Phase DNA Detection

  2026-08-15

  EdU Imaging Kits (Cy3) provide a 5-ethynyl-2'-deoxyuridine imaging kit workflow for labeling nascent DNA without antibody-based DNA denaturation. The Cy3 click-chemistry readout supports fluorescence microscopy, flow cytometry, and controlled cell proliferation or genotoxicity studies.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Assay Strategy

  2026-08-14

  Learn how the Cy3 Goat Anti-Rabbit IgG (H+L) Antibody supports mechanistically rigorous immunofluorescence, IHC, and ICC workflows. This guide connects reagent selection with pathway-level interpretation using recent rheumatoid arthritis research as a practical model.

• A-1331852: BCL-XL Inhibition in Glioblastoma

  2026-08-14

  A-1331852 is a selective BCL-XL inhibitor for dissecting apoptotic dependence in glioblastoma and other cancer models. This article connects BCL-XL–BIM complex disruption with apoptotic priming, assay design, and translational limitations.

• Podophyllotoxin Workflows for HCC and Autophagy

  2026-08-13

  Build reproducible Podophyllotoxin assays around microtubule disruption, G2/M arrest, apoptosis, and autophagy flux. This guide distinguishes direct compound testing from mechanistically related hepatocellular carcinoma research and provides practical preparation, optimization, and troubleshooting strategies.

• 5-Azacytidine: From Demethylation to DNA Damage

  2026-08-13

  5-Azacytidine is more than a DNA demethylation agent: it can create DNMT-linked DNA damage and ATR-associated apoptotic signaling. This guide translates that dual biology into better assay design for leukemia and multiple myeloma research.

• AO/PI Double Staining Kit: Practical Workflow

  2026-08-12

  The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that separates viable, apoptosis-associated, and membrane-compromised cell populations in one staining workflow. It is intended for fluorescence-based research readouts and should not be treated as a standalone molecular confirmation of apoptosis or as a non-fluorescent assay.

• EdU Cell Proliferation Kit for RA FLS Studies

  2026-08-12

  Translate ARL4C-driven synoviocyte biology into a direct, non-radioactive S-phase readout with the EdU Cell Proliferation Kit (TMB). This workflow supports rheumatoid arthritis mechanism studies, genotoxicity testing assay design, and pharmacodynamic drug evaluation while highlighting controls that prevent common interpretation errors.

• 5-Azacytidine Workflows for DNA Demethylation

  2026-08-11

  Build more informative 5-Azacytidine experiments by separating DNA demethylation from DNA-damage-driven cytotoxicity. This workflow guide covers formulation, dose selection, orthogonal readouts, combination studies, and practical troubleshooting for leukemia and multiple myeloma models.

• 5-Azacytidine: From DNMT Trapping to GBM Immunity

  2026-08-11

  5-Azacytidine is more than a DNA demethylation agent: its effects depend on replication, chromatin context, and immune-state biology. This article explains how 5-AzaC supports pathway-aware glioblastoma assays, including the ERV–MAVS–IFN findings revealed by recent research.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-08-10

  Build a rapid cell-death workflow that separates viable, early apoptotic, late apoptotic, and necrotic populations in 10–20 minutes. The assay is especially useful for mapping drug-induced apoptosis onto the calcium, mitochondrial, and PI3K/Akt findings reported in Ph+ ALL research.

• ZCL278: Selective Cdc42 Inhibitor Guide

  2026-08-09

  ZCL278 is a selective Cdc42 inhibitor for studying Cdc42 signaling, cell motility, and neuronal morphology. Its reported biochemical affinity, cell-based phenotypes, formulation limits, and research-only status define a useful but nonclinical experimental tool.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide

  2026-08-08

  This scenario-driven guide explains how Cy3 Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1209, can strengthen fluorescence-based validation of cell viability, proliferation, and cytotoxicity experiments. It connects practical assay controls, storage, interpretation, and vendor-selection criteria with evidence from a PBDE-47 neutrophil extracellular trap study.

• Cisplatin and Oral Cancer Stemness: A Translational Roadmap

  2026-08-07

  Cisplatin remains a powerful DNA-damaging benchmark, but its translational value increasingly depends on understanding which tumor cell states survive treatment. This article connects CDDP mechanism, oral cancer stemness, ITGA2 biology, experimental design, and resistance-focused combination strategies for researchers building more predictive oncology models.

• A 83-01: Optimizing ALK-5 Inhibition in Organoid Research

  2026-08-07

  A 83-01, a potent ALK-5 inhibitor, empowers precise TGF-β pathway modulation in advanced organoid and stem cell models. This guide explores workflow integration, troubleshooting, and protocol fine-tuning to maximize reproducibility and translational relevance.

• EdU Imaging Kits (Cy3): High-Fidelity S-Phase DNA Synthesis

  2026-08-06

  EdU Imaging Kits (Cy3) from APExBIO offer precise, denaturation-free detection of DNA synthesis during the cell cycle S-phase. Utilizing click chemistry, these kits deliver high sensitivity and specificity for cell proliferation assays. Their robust workflow simplifies fluorescence microscopy and flow cytometry applications, outperforming traditional BrdU-based methods.

3582 records 3/239 page Previous Next 12345 下5页 Last page